Near Infrared (NIR) Autofluorescence Image-guided Thyroid Surgery

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT04193332
Collaborator
Cluster for molecular imaging, Denmark (Other), Dept of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Denmark (Other)
214
2
2
51.5
107
2.1

Study Details

Study Description

Brief Summary

The objective of this ongoing randomized controlled trial is to examine whether the use of intra-operative NIR(near infrared) camera can reduce the number of patients who experience transient or persistent hypoparathyroidism after total thyroidectomy and completion thyroidectomy, both in malignant and benign thyroid disease.

Condition or Disease Intervention/Treatment Phase
  • Device: NIR optical imaging camera
N/A

Detailed Description

Patients admitted to total thyroidectomy or completion thyroidectomy is ramdomized to:
  1. Intervention: NIR optic imaging assisted identification of the parathyroid glands during thyroidectomy using parathyroid gland autofluorescence.

  2. Control: Conventional thyroidectomy and parathyroid identification by the surgeon.

Measurements:

PTH and ionized-Ca blood samples are collected preoperatively, within 12 hours postoperatively and at 1-, 3-, 9- and 12-months follow-up.

Anticipated 214 patients are included, all of which participate in 3 months follow-up. Only patients with persistent hypoparathyroidism at this point continue til maximum 12 months follow-up.

An interim analysis will be conducted when inclusion of anticipated 128 patients and 3 months follow-up is reached.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
214 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Near Infrared (NIR) Autofluorescence Image-guided Thyroid Surgery Can Prevent Post-thyroidectomy Hypoparathyroidism
Actual Study Start Date :
Aug 16, 2019
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Plus NIR optical imaging

NIR optical imaging assisted identification of parathyroid glands during thyroid surgery

Device: NIR optical imaging camera
NIR optical imaging assisted identification of parathyroid glands during thyroid surgery using parathyroid gland autofluorescense

No Intervention: Minus NIR optical imaging

Conventional identification of parathyroid glands during thyroid surgery

Outcome Measures

Primary Outcome Measures

  1. Postoperative hypoparathyroidism [24 months-follow-up]

    Hypoparathyroidism defined as: PTH < 1,6 pmol/L and based on European Society of Endocrinology Clinical Guideline

Secondary Outcome Measures

  1. Postoperative hypocalcemia [12 months follow-up]

    Hypocalcemia defined as: ionized Calcium < 1,15 mmol/L

  2. Time [Immediately after surgery]

    Duration of surgery

  3. Parathyroidglands identified by NIR light [During surgery]

    Number of identified by NIR light vs. white light

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Able to understand patient information and to give written informed consent

  • Patients admitted to either total thyroidectomy og completion thyroidectomy, both benign and malign.

Exclusion Criteria:
  • Not able to understand patient information and to give written informed consent

  • Previous parathyroid surgery or other parathyroid decease

  • Age under 18

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rigshospitalet Copenhagen Denmark 2100
2 Dept of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Denmark Køge Denmark 4600

Sponsors and Collaborators

  • Rigshospitalet, Denmark
  • Cluster for molecular imaging, Denmark
  • Dept of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Denmark

Investigators

  • Study Director: Christian von Buchwald, MDSc, PhD, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eva Lykke, Principal investigator, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT04193332
Other Study ID Numbers:
  • H19010211
First Posted:
Dec 10, 2019
Last Update Posted:
Feb 14, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eva Lykke, Principal investigator, Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2022